Related Experiment Video
Updated: Feb 19, 2026

Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
Veno-venous ECMO for rapidly progressing interstitial lung disease: A multidisciplinary approach
Samreen Tariq1, Fiona O'Hannigan1, Nizrull Nasir1
1Mater Misericordiae University Hospital, Dublin, Ireland.
Antisynthetase syndrome (ASS) can cause severe, rapidly progressing interstitial lung disease (ILD) leading to respiratory failure. Early, aggressive multi-modal treatment, including ECMO, is crucial for patient recovery.
Area of Science:
- Pulmonology
- Rheumatology
- Critical Care Medicine
Background:
- Antisynthetase syndrome (ASS) is a rare autoimmune disorder.
- It can manifest as interstitial lung disease (ILD) with rapid progression.
- Prompt diagnosis and treatment are vital to prevent severe morbidity and mortality.
More Related Videos
03:40Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting
Published on: January 17, 2025
09:54Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Embolism III: Nursing Management
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pulmonary Embolism I: Introduction